Toshimitsu Fujii

13PUBLICATIONS
33CO-AUTHORS
Immunogenetics (incl. genetic immunology)AutoimmunityIntensive careBehavioural epidemiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 21, 2026
Case Report of a Rapidly Progressive Indolent T-Cell Lymphoma of the Gastrointestinal Tract.

|May 02, 2026
A case of immune-mediated adverse events enterocolitis and duodenitis with gastrointestinal bleeding successfully treated with ustekinumab.

|Mar 16, 2026
Efficacy and Rapid Response of Ustekinumab for Hospitalized Patients With Severe Ulcerative Colitis.

Akiko Tamura, Toshimitsu Fujii, Shun Fujiwara

|Jul 31, 2025
Letter: Efficacy Versus Effectiveness-An Important Nuance Among Real-World Studies: Authors' Reply.

Shintaro Akiyama, Toshimitsu Fujii

|May 15, 2025
Real-World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus < 70 Years With Ulcerative Colitis: Multicenter Retrospective Study.

Tadakazu Hisamatsu, Taku Kobayashi, Satoshi Motoya

|Jan 23, 2025
Letter: Toward Intra-Class Switching With JAK Inhibitors? Authors' Reply.

Shintaro Akiyama, Toshimitsu Fujii

Pageof 3

Frequent Collaborators

5 joint publications

Shintaro Akiyama

4 joint publications

Ryuichi Okamoto

4 joint publications

Ami Kawamoto

4 joint publications

Kento Takenaka